Ahuja, Dharmendra (2025) Cloud-Powered Drug Discovery and Personalized Medicine: Revolutionizing Healthcare Through Advanced Technology. World Journal of Advanced Engineering Technology and Sciences, 16 (1). 098-110. ISSN 2582-8266
![WJAETS-2025-1050.pdf [thumbnail of WJAETS-2025-1050.pdf]](https://eprint.scholarsrepository.com/style/images/fileicons/text.png)
WJAETS-2025-1050.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike.
Abstract
Cloud computing integration with artificial intelligence and machine learning has fundamentally transformed drug discovery and personalized medicine by revolutionizing traditional pharmaceutical development processes. The convergence of these technologies enables rapid processing of molecular and clinical data while significantly reducing development timelines through advanced computational methods and scalable infrastructure. Machine learning pipelines combined with robust security frameworks accelerate drug candidate identification and optimization processes. Modern cloud platforms facilitate seamless collaboration among globally distributed teams while maintaining regulatory compliance and data security standards. Advanced ML pipeline implementations demonstrate enhanced capabilities in deep learning architectures and sophisticated neural network systems for processing complex molecular structures. Technical implementation examples showcase remarkable achievements in genomic data processing, protein structure prediction systems, and high-performance computing integration. Cloud infrastructure delivers substantial benefits, including scalability advantages, cost efficiency improvements, and accelerated development timelines. Future technical directions indicate continued evolution toward hybrid cloud architectures, enhanced AI capabilities, and emerging technologies integration. The pharmaceutical industry increasingly adopts cloud-native MLOps tools that streamline development and deployment of machine learning models while ensuring reproducibility and governance requirements are met across all stages of drug development.
Item Type: | Article |
---|---|
Official URL: | https://doi.org/10.30574/wjaets.2025.16.1.1050 |
Uncontrolled Keywords: | Cloud-powered drug discovery; Artificial intelligence in pharmaceuticals; Machine learning pipelines; Personalized medicine automation; Drug development optimization |
Depositing User: | Editor Engineering Section |
Date Deposited: | 22 Aug 2025 07:20 |
Related URLs: | |
URI: | https://eprint.scholarsrepository.com/id/eprint/5205 |